Ursheet Parikh, partner at Mayfield and investor in Mammoth Biosciences, observes that platform biotech companies should create a culture focused on goals and accountability. To manage risk while building for the long haul, he shares Mammoth’s approach of breaking big problems into smaller tasks and being deliberate in the planning and strategy phase.

Video clips from: Building Biotech to Last [Entire Talk]

4 minutes

A Built-to-Last Biotech Mindset

Watch now

3 minutes

Aligning with Investors

Watch now

3 minutes

Market Selection for Biotech Platforms

Watch now

3 minutes

Bioethics from the Beginning

Watch now

4 minutes

Creating a Culture of Accountability in Biotech

Watch now

Share Post